Cargando…
A PRISMA-compliant systematic review and network meta-analysis on the efficacy between different regimens based on Tripterygium wilfordii Hook F in patients with primary nephrotic syndrome
BACKGROUND: The present study aims to comprehensively determine the efficacy of different therapy regimens based on Tripterygium wilfordii Hook F (TwHF) for patients with primary nephrotic syndrome (PNS) using network meta-analysis method. METHODS: Seven electronic databases were searched to identif...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6076150/ https://www.ncbi.nlm.nih.gov/pubmed/29979395 http://dx.doi.org/10.1097/MD.0000000000011282 |
_version_ | 1783344654507311104 |
---|---|
author | Wang, Xin-bin Dai, En-lai Xue, Guo-zhong Ma, Rui-ling |
author_facet | Wang, Xin-bin Dai, En-lai Xue, Guo-zhong Ma, Rui-ling |
author_sort | Wang, Xin-bin |
collection | PubMed |
description | BACKGROUND: The present study aims to comprehensively determine the efficacy of different therapy regimens based on Tripterygium wilfordii Hook F (TwHF) for patients with primary nephrotic syndrome (PNS) using network meta-analysis method. METHODS: Seven electronic databases were searched to identify randomized controlled trials (RCTs) that compared the differences between different therapy regimens based on TwHF for patients with PNS. The risk of bias in included RCTs was evaluated according to the Cochrane Handbook version 5.2.0. Network meta-analysis was performed to compare different regimens. Primary outcomes were complete remission rate and total remission rate. The secondary outcomes were hr urinary protein excretion, serum albumin, serum creatinine, and urea nitrogen. Data analysis was performed using R software. RESULTS: A total of 40 studies involving 2846 patients with PNS were included. Compared with prednisone, the improvement in total remission rate and complete remission rate was associated with TwHF alone (odds ratio [OR] = 4.80, 95% credible intervals [CrI]: 2.20–10.00; OR = 6.30, 95% CrI: 2.90–13.00, respectively), TwHF+prednisone (OR = 2.10, 95% CrI: 1.30–3.50; OR = 2.40, 95% CrI: 1.50–3.80, respectively), TwHF+CPA (OR = 12.00, 95% CrI: 1.10–150.00; OR = 16.00, 95% CrI: 1.60–170.00, respectively), and TwHF+Cyclosporine A (OR = 28.00, 95% CrI: 3.20–250.00; OR = 35.00, 95% CrI: 4.50–270.00, respectively). Compared with TwHF alone, TwHF+prednisone showed less benefit in improving total remission rate and complete remission rate (OR = 0.44, 95% CrI: 0.21–0.91; OR = 0.38, 95% CrI: 0.19–0.77, respectively). TwHF alone, TwHF+prednisone could significantly reduce hr urinary protein excretion (MD = −0.69, 95% CrI: −1.30 to −0.14; MD = −1.00, 95% CrI: −1.90 to −0.14, respectively) and increase serum albumin (MD = 5.90, 95% CrI: 2.50–9.30; MD = 3.40, 95% CrI: 1.30–5.50, respectively) when compared to prednisone alone. TwHF alone showed significant reduction in serum creatinine when compared to CPA (MD = −19.00, 95% CrI: −37.00 to −0.56). CONCLUSIONS: TwHF alone, the addition TwHF to prednisone showed more benefit in improving total and complete remission rate, hr urinary protein excretion, serum albumin, and serum creatinine. |
format | Online Article Text |
id | pubmed-6076150 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-60761502018-08-17 A PRISMA-compliant systematic review and network meta-analysis on the efficacy between different regimens based on Tripterygium wilfordii Hook F in patients with primary nephrotic syndrome Wang, Xin-bin Dai, En-lai Xue, Guo-zhong Ma, Rui-ling Medicine (Baltimore) Research Article BACKGROUND: The present study aims to comprehensively determine the efficacy of different therapy regimens based on Tripterygium wilfordii Hook F (TwHF) for patients with primary nephrotic syndrome (PNS) using network meta-analysis method. METHODS: Seven electronic databases were searched to identify randomized controlled trials (RCTs) that compared the differences between different therapy regimens based on TwHF for patients with PNS. The risk of bias in included RCTs was evaluated according to the Cochrane Handbook version 5.2.0. Network meta-analysis was performed to compare different regimens. Primary outcomes were complete remission rate and total remission rate. The secondary outcomes were hr urinary protein excretion, serum albumin, serum creatinine, and urea nitrogen. Data analysis was performed using R software. RESULTS: A total of 40 studies involving 2846 patients with PNS were included. Compared with prednisone, the improvement in total remission rate and complete remission rate was associated with TwHF alone (odds ratio [OR] = 4.80, 95% credible intervals [CrI]: 2.20–10.00; OR = 6.30, 95% CrI: 2.90–13.00, respectively), TwHF+prednisone (OR = 2.10, 95% CrI: 1.30–3.50; OR = 2.40, 95% CrI: 1.50–3.80, respectively), TwHF+CPA (OR = 12.00, 95% CrI: 1.10–150.00; OR = 16.00, 95% CrI: 1.60–170.00, respectively), and TwHF+Cyclosporine A (OR = 28.00, 95% CrI: 3.20–250.00; OR = 35.00, 95% CrI: 4.50–270.00, respectively). Compared with TwHF alone, TwHF+prednisone showed less benefit in improving total remission rate and complete remission rate (OR = 0.44, 95% CrI: 0.21–0.91; OR = 0.38, 95% CrI: 0.19–0.77, respectively). TwHF alone, TwHF+prednisone could significantly reduce hr urinary protein excretion (MD = −0.69, 95% CrI: −1.30 to −0.14; MD = −1.00, 95% CrI: −1.90 to −0.14, respectively) and increase serum albumin (MD = 5.90, 95% CrI: 2.50–9.30; MD = 3.40, 95% CrI: 1.30–5.50, respectively) when compared to prednisone alone. TwHF alone showed significant reduction in serum creatinine when compared to CPA (MD = −19.00, 95% CrI: −37.00 to −0.56). CONCLUSIONS: TwHF alone, the addition TwHF to prednisone showed more benefit in improving total and complete remission rate, hr urinary protein excretion, serum albumin, and serum creatinine. Wolters Kluwer Health 2018-07-06 /pmc/articles/PMC6076150/ /pubmed/29979395 http://dx.doi.org/10.1097/MD.0000000000011282 Text en Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 |
spellingShingle | Research Article Wang, Xin-bin Dai, En-lai Xue, Guo-zhong Ma, Rui-ling A PRISMA-compliant systematic review and network meta-analysis on the efficacy between different regimens based on Tripterygium wilfordii Hook F in patients with primary nephrotic syndrome |
title | A PRISMA-compliant systematic review and network meta-analysis on the efficacy between different regimens based on Tripterygium wilfordii Hook F in patients with primary nephrotic syndrome |
title_full | A PRISMA-compliant systematic review and network meta-analysis on the efficacy between different regimens based on Tripterygium wilfordii Hook F in patients with primary nephrotic syndrome |
title_fullStr | A PRISMA-compliant systematic review and network meta-analysis on the efficacy between different regimens based on Tripterygium wilfordii Hook F in patients with primary nephrotic syndrome |
title_full_unstemmed | A PRISMA-compliant systematic review and network meta-analysis on the efficacy between different regimens based on Tripterygium wilfordii Hook F in patients with primary nephrotic syndrome |
title_short | A PRISMA-compliant systematic review and network meta-analysis on the efficacy between different regimens based on Tripterygium wilfordii Hook F in patients with primary nephrotic syndrome |
title_sort | prisma-compliant systematic review and network meta-analysis on the efficacy between different regimens based on tripterygium wilfordii hook f in patients with primary nephrotic syndrome |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6076150/ https://www.ncbi.nlm.nih.gov/pubmed/29979395 http://dx.doi.org/10.1097/MD.0000000000011282 |
work_keys_str_mv | AT wangxinbin aprismacompliantsystematicreviewandnetworkmetaanalysisontheefficacybetweendifferentregimensbasedontripterygiumwilfordiihookfinpatientswithprimarynephroticsyndrome AT daienlai aprismacompliantsystematicreviewandnetworkmetaanalysisontheefficacybetweendifferentregimensbasedontripterygiumwilfordiihookfinpatientswithprimarynephroticsyndrome AT xueguozhong aprismacompliantsystematicreviewandnetworkmetaanalysisontheefficacybetweendifferentregimensbasedontripterygiumwilfordiihookfinpatientswithprimarynephroticsyndrome AT maruiling aprismacompliantsystematicreviewandnetworkmetaanalysisontheefficacybetweendifferentregimensbasedontripterygiumwilfordiihookfinpatientswithprimarynephroticsyndrome AT wangxinbin prismacompliantsystematicreviewandnetworkmetaanalysisontheefficacybetweendifferentregimensbasedontripterygiumwilfordiihookfinpatientswithprimarynephroticsyndrome AT daienlai prismacompliantsystematicreviewandnetworkmetaanalysisontheefficacybetweendifferentregimensbasedontripterygiumwilfordiihookfinpatientswithprimarynephroticsyndrome AT xueguozhong prismacompliantsystematicreviewandnetworkmetaanalysisontheefficacybetweendifferentregimensbasedontripterygiumwilfordiihookfinpatientswithprimarynephroticsyndrome AT maruiling prismacompliantsystematicreviewandnetworkmetaanalysisontheefficacybetweendifferentregimensbasedontripterygiumwilfordiihookfinpatientswithprimarynephroticsyndrome |